1
Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:March 19, 2021Not yet recruiting
Anakinra: 406 Clinical Trials, Page 1 of 41
Hide Studies Not Open or Pending
2
Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
Condition(s):Endometriosis; Anakinra; Markers of InflammationLast Updated:April 7, 2020Recruiting
3
Anakinra, COVID-19, Cytokine Storm
Condition(s):Covid19; Cytokine Storm; Mechanical Ventilation ComplicationLast Updated:March 25, 2021Not yet recruiting
4
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
Condition(s):COVID-19; Virus Diseases; Corona Virus Infection; Lower Respiratory Tract Infection ViralLast Updated:February 15, 2021Recruiting
5
suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
Condition(s):Covid19Last Updated:April 5, 2021Active, not recruiting
6
Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT
Condition(s):Multiple MyelomaLast Updated:November 24, 2020Completed
7
Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Condition(s):Kawasaki DiseaseLast Updated:June 5, 2020Recruiting
8
Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
Condition(s):Hearing Loss, SuddenLast Updated:March 13, 2017Terminated
9
Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition(s):Still Disease, Juvenile OnsetLast Updated:November 14, 2019Completed
10
Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
Condition(s):COVID-19 PnemoniaLast Updated:June 23, 2020Recruiting